Resource library search

The Microbiology Society welcomes the proposal to reform the water industry as detailed in their white paper, ‘A New Vision for Water’,  published on 20 January 2026.  

The Microbiology Society and the Association of Laboratory Medicine have joined forces to respond to the Department of Health and Social Care’s (DHSC) consultation on enabling pharmacists flexibilities when dispensing medicines.

The Microbiology Society was proud to lead a policy workshop at this year's Innovations Against AMR Summit, held at the University of Warwick, UK.  

A new policy briefing on the evolving research around biofilms and the challenges of tackling them in order to improve antibiotic treatments.

The Microbiology Society has submitted evidence to the UK Parliament’s Science, Innovation and Technology Committee as part of the Committee’s inquiry into innovation and global food security.

Microbes do not exist in isolation. Instead, they live in complex and dynamic communities in which different microbial species are constantly interacting. When these communities are combined with a specific host (for example, humans, animals and plants) or environment (for example, soil and oceans), we refer to the ecosystem as a microbiome.

Antimicrobial resistance (AMR) is one of the most pressing global health threats of our time, undermining the efficacy of life-saving treatments and placing a growing burden on health systems worldwide. While vaccines are recognised for their ability to prevent infections and reduce antibiotic use, thereby slowing the emergence of resistance, their role in addressing AMR remains underexploited in both policy and practice.

The UK Health Security Agency (UKHSA) is looking for feedback on the effectiveness of the current format of UK Standards for Microbiology Investigations (UK SMI) syndromic documents.
 

The Microbiology Society is coordinating a response to a call for evidence by the UK Parliament’s Science, Innovation and Technology committee, as part of the committee’s inquiry on innovation and global food security.

The Microbiology Society expresses concern over the UK Government’s decision to cut funding to the Fleming Fund, a flagship global health programme working to combat antimicrobial resistance (AMR) in low- and middle-income countries (LMICs). The Fleming Fund is the world’s largest aid-funded initiative focused on AMR surveillance and capacity building. These cuts threaten to undermine vital progress in one of the most pressing global health challenges of our time.

In March 2025, the Microbiology Society submitted a response to the UK Parliament’s Public Accounts Committee (PAC) inquiry into antimicrobial resistance (AMR). We are pleased to share that our evidence was considered and quoted in the final inquiry report, which was published last week.

As Ireland’s Second One Health Nation Action Plan (iNAP2) on AMR concludes, the Microbiology Society urges a stronger role for researchers in shaping the next phase of national policy.

UK Health Security Agency (UKHSA)’s antimicrobial resistance (AMR) & Healthcare-associated infection (HCAI) division, together with the Evaluation & Epidemiological Science division, are working on an assessment to improve UKHSA-provided surveillance outputs related to the AMR national action plan 2024-2029. These include surveillance statistics and monitoring data on various bacterial and fungal infections, antimicrobial use, pathogen resistance rates and antimicrobial stewardship.

The Microbiology Society is contributing to an online survey launched by Quadripartite Joint Secrerariat on AMR, as part of the formal consultation process for updating the Global Action Plan on Antimicrobial Resistance (GAP-AMR). 

The Microbiology Society has coordinated a response to a consultation launched by NHS England on their 10-year plan.